‘We haven’t seen the safety concerns in the individuals that we’ve prescribed it for’

An antimalarial drug commonly prescribed in Alberta is facing growing calls from critics who want it downgraded as a drug of “last resort” for travellers.

“I am concerned Alberta prescribers are not fully taking into consideration the very significant level of risk acknowledged by the latest product monograph,” said Dr. Remington Nevin, a former U.S. Army major and leading expert on the neuropsychiatric side effects of mefloquine.

“The reason Canadian travellers have been placed at risk for the last few years is that … the Canadian government is still in denial about the drug’s true dangers.”